{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:10:40Z","timestamp":1764079840085,"version":"3.37.3"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1200287","3210276"],"award-info":[{"award-number":["1200287","3210276"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study investigates the possible therapeutic effects of human mesenchymal stem cell-derived secretome on morphine dependence and relapse. This was studied in a new model of chronic voluntary morphine intake in Wistar rats which shows classic signs of morphine intoxication and a severe naloxone-induced withdrawal syndrome. A single intranasal-systemic administration of MSCs secretome fully inhibited (&gt;95%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) voluntary morphine intake and reduced the post-deprivation relapse intake by 50% (p\u2009&lt;\u20090.02). Since several studies suggest a significant genetic contribution to the chronic use of many addictive drugs, the effect of MSCs secretome on morphine self-administration was further studied in rats bred as high alcohol consumers (UChB rats). Sub-chronic intraperitoneal administration of morphine before access to increasing concentrations of morphine solutions and water were available to the animals, led UChB rats to prefer ingesting morphine solutions over water, attaining levels of oral morphine intake in the range of those in the Wistar model. Intranasally administered MSCs secretome to UChB rats dose-dependently inhibited morphine self-administration by 72% (p\u2009&lt;\u20090.001); while a single intranasal dose of MSC-secretome administered during a morphine deprivation period imposed on chronic morphine consumer UChB rats inhibited re-access morphine relapse intake by 80 to 85% (p\u2009&lt;\u20090.0001). Both in the Wistar and the UChB rat models, MSCs-secretome administration reversed the morphine-induced increases in brain oxidative stress and neuroinflammation, considered as key engines perpetuating drug relapse. Overall, present preclinical studies suggest that products secreted by human mesenchymal stem cells may be of value in the treatment of opioid addiction.<\/jats:p>","DOI":"10.1038\/s41398-022-02225-0","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T11:27:21Z","timestamp":1667561241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence"],"prefix":"10.1038","volume":"12","author":[{"given":"Mar\u00eda Elena","family":"Quintanilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Berr\u00edos-C\u00e1rcamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Santapau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Ezquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Herrera-Marschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yedy","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7696-4215","authenticated-orcid":false,"given":"Fernando","family":"Ezquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"2225_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","volume":"67","author":"P Seth","year":"2018","unstructured":"Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants-United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67:349\u201358.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2225_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394:1560\u201379.","journal-title":"Lancet"},{"key":"2225_CR3","unstructured":"WHO. Opiate Overdose. https:\/\/www.whoint\/news-room\/fact-sheets\/detail\/opioid-overdose 2021."},{"key":"2225_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-publhealth-082619-104231","volume":"42","author":"S Harper","year":"2021","unstructured":"Harper S, Riddell CA, King NB. Declining Life Expectancy in the United States: Missing the Trees for the Forest. Annu Rev Public Health. 2021;42:381\u2013403.","journal-title":"Annu Rev Public Health"},{"key":"2225_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhealeco.2019.01.001","volume":"64","author":"CJ Ruhm","year":"2019","unstructured":"Ruhm CJ. Drivers of the fatal drug epidemic. J Health Econ. 2019;64:25\u201342.","journal-title":"J Health Econ"},{"key":"2225_CR6","first-page":"CD002207","volume":"2","author":"RP Mattick","year":"2008","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;2:CD002207.","journal-title":"Cochrane Database Syst Rev"},{"key":"2225_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","volume":"68","author":"RD Weiss","year":"2011","unstructured":"Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238\u201346.","journal-title":"Arch Gen Psychiatry"},{"key":"2225_CR8","doi-asserted-by":"crossref","unstructured":"Berrios-Carcamo P, Quezada M, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, et al. Oxidative stress and neuroinflammation as a pivot in drug abuse. a focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants (Basel). 2020;9.","DOI":"10.3390\/antiox9090830"},{"key":"2225_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.neuropharm.2005.01.018","volume":"48","author":"JB Dietrich","year":"2005","unstructured":"Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology. 2005;48:965\u201374.","journal-title":"Neuropharmacology"},{"key":"2225_CR10","doi-asserted-by":"crossref","unstructured":"Berrios-Carcamo P, Quezada M, Santapau D, Morales P, Olivares B, Ponce C, et al. A novel morphine drinking model of opioid dependence in rats. Int J Mol Sci. 2022; 23.","DOI":"10.3390\/ijms23073874"},{"key":"2225_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1570193X113106660031","volume":"10","author":"J Skrabalova","year":"2013","unstructured":"Skrabalova J, Drastichova Z, Novotny J. Morphine as a potential oxidative stress-causing agent. Mini Rev Org Chem. 2013;10:367\u201372.","journal-title":"Mini Rev Org Chem"},{"key":"2225_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cobeha.2016.12.003","volume":"13","author":"CM Cahill","year":"2017","unstructured":"Cahill CM, Taylor AM. Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence. Curr Opin Behav Sci. 2017;13:171\u20137.","journal-title":"Curr Opin Behav Sci"},{"key":"2225_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0168-0102(00)00226-1","volume":"39","author":"P Song","year":"2001","unstructured":"Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res. 2001;39:281\u20136.","journal-title":"Neurosci Res"},{"key":"2225_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/npp.2016.131","volume":"42","author":"LN Eidson","year":"2017","unstructured":"Eidson LN, Inoue K, Young LJ, Tansey MG, Murphy AZ. Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling. Neuropsychopharmacology. 2017;42:661\u201370.","journal-title":"Neuropsychopharmacology"},{"key":"2225_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","volume":"38","author":"HL Fields","year":"2015","unstructured":"Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38:217\u201325.","journal-title":"Trends Neurosci"},{"key":"2225_CR16","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","volume":"99","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol Rev. 2019;99:2115\u201340.","journal-title":"Physiol Rev"},{"key":"2225_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1124\/pr.116.012484","volume":"68","author":"MD Scofield","year":"2016","unstructured":"Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith AC, et al. The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharm Rev. 2016;68:816\u201371.","journal-title":"Pharm Rev"},{"key":"2225_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nlm.2018.02.007","volume":"154","author":"D Neuhofer","year":"2018","unstructured":"Neuhofer D, Kalivas P. Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction. Neurobiol Learn Mem. 2018;154:97\u2013111.","journal-title":"Neurobiol Learn Mem"},{"key":"2225_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"2225_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1\u2013105.","journal-title":"Prog Neurobiol"},{"key":"2225_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","volume":"19","author":"D Trotti","year":"1998","unstructured":"Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharm Sci. 1998;19:328\u201334.","journal-title":"Trends Pharm Sci"},{"key":"2225_CR22","doi-asserted-by":"publisher","first-page":"108114","DOI":"10.1016\/j.abb.2019.108114","volume":"674","author":"M Ghasemitarei","year":"2019","unstructured":"Ghasemitarei M, Yusupov M, Razzokov J, Shokri B, Bogaerts A. Effect of oxidative stress on cystine transportation by xC antiporter. Arch Biochem Biophys. 2019;674:108114.","journal-title":"Arch Biochem Biophys"},{"key":"2225_CR23","doi-asserted-by":"publisher","first-page":"e1005643","DOI":"10.1371\/journal.ppat.1005643","volume":"12","author":"CN David","year":"2016","unstructured":"David CN, Frias ES, Szu JI, Vieira PA, Hubbard JA, Lovelace J, et al. GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite toxoplasma gondii. PLoS Pathog. 2016;12:e1005643.","journal-title":"PLoS Pathog"},{"key":"2225_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.febslet.2013.11.033","volume":"588","author":"L Kastl","year":"2014","unstructured":"Kastl L, Sauer SW, Ruppert T, Beissbarth T, Becker MS, Suss D, et al. TNF-alpha mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-kappaB activation in liver cells. FEBS Lett. 2014;588:175\u201383.","journal-title":"FEBS Lett"},{"key":"2225_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.imlet.2015.08.007","volume":"168","author":"A Laroni","year":"2015","unstructured":"Laroni A, de Rosbo NK, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection. Immunol Lett. 2015;168:183\u201390.","journal-title":"Immunol Lett"},{"key":"2225_CR26","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/j.1471-4159.2009.06268.x","volume":"110","author":"C Lanza","year":"2009","unstructured":"Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD, et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem. 2009;110:1674\u201384.","journal-title":"J Neurochem"},{"key":"2225_CR27","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1089\/scd.2014.0088","volume":"23","author":"B Hegyi","year":"2014","unstructured":"Hegyi B, Kornyei Z, Ferenczi S, Fekete R, Kudlik G, Kovacs KJ, et al. Regulation of mouse microglia activation and effector functions by bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2014;23:2600\u201312.","journal-title":"Stem Cells Dev"},{"key":"2225_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/sctm.19-0446","volume":"9","author":"R Stavely","year":"2020","unstructured":"Stavely R, Nurgali K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med. 2020;9:985\u20131006.","journal-title":"Stem Cells Transl Med"},{"key":"2225_CR29","doi-asserted-by":"publisher","first-page":"3924858","DOI":"10.1155\/2016\/3924858","volume":"2016","author":"A Saparov","year":"2016","unstructured":"Saparov A, Ogay V, Nurgozhin T, Jumabay M, Chen WC. Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response. Stem Cells Int. 2016;2016:3924858.","journal-title":"Stem Cells Int"},{"key":"2225_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/adb.12572","volume":"24","author":"F Ezquer","year":"2019","unstructured":"Ezquer F, Quintanilla ME, Morales P, Ezquer M, Lespay-Rebolledo C, Herrera-Marschitz M, et al. Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse-like drinking in high-alcohol drinker rats. Addict Biol. 2019;24:17\u201327.","journal-title":"Addict Biol"},{"key":"2225_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/alcalc\/agw068","volume":"52","author":"Y Israel","year":"2017","unstructured":"Israel Y, Ezquer F, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M. Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats. Alcohol Alcohol. 2017;52:1\u20134.","journal-title":"Alcohol Alcohol"},{"key":"2225_CR32","doi-asserted-by":"crossref","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019; 8.","DOI":"10.3390\/cells8050467"},{"key":"2225_CR33","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","volume":"70","author":"FG Teixeira","year":"2013","unstructured":"Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013;70:3871\u201382.","journal-title":"Cell Mol Life Sci"},{"key":"2225_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13287-019-1304-z","volume":"10","author":"ME Quintanilla","year":"2019","unstructured":"Quintanilla ME, Ezquer F, Morales P, Santapau D, Berrios-Carcamo P, Ezquer M, et al. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Res Ther. 2019;10:205.","journal-title":"Stem Cell Res Ther"},{"key":"2225_CR35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/acer.13842","volume":"42","author":"ME Quintanilla","year":"2018","unstructured":"Quintanilla ME, Morales P, Ezquer F, Ezquer M, Herrera-Marschitz M, Israel Y. Commonality of ethanol and nicotine reinforcement and relapse in Wistar-Derived UChB Rats: Inhibition by N-Acetylcysteine. Alcohol Clin Exp Res. 2018;42:1988\u201399.","journal-title":"Alcohol Clin Exp Res"},{"key":"2225_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnbeh.2017.00057","volume":"11","author":"Y Israel","year":"2017","unstructured":"Israel Y, Karahanian E, Ezquer F, Morales P, Ezquer M, Rivera-Meza M, et al. Acquisition, maintenance and relapse-like alcohol drinking: lessons from the UChB Rat Line. Front Behav Neurosci. 2017;11:57.","journal-title":"Front Behav Neurosci"},{"key":"2225_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1369-1600.2006.00030.x","volume":"11","author":"ME Quintanilla","year":"2006","unstructured":"Quintanilla ME, Israel Y, Sapag A, Tampier L. The UChA and UChB rat lines: metabolic and genetic differences influencing ethanol intake. Addict Biol. 2006;11:310\u201323.","journal-title":"Addict Biol"},{"key":"2225_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00426903","volume":"58","author":"BK Alexander","year":"1978","unstructured":"Alexander BK, Coambs RB, Hadaway PF. The effect of housing and gender on morphine self-administration in rats. Psychopharmacol (Berl). 1978;58:175\u20139.","journal-title":"Psychopharmacol (Berl)"},{"key":"2225_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0091-3057(02)01039-0","volume":"74","author":"TJ Cicero","year":"2003","unstructured":"Cicero TJ, Aylward SC, Meyer ER. Gender differences in the intravenous self-administration of mu opiate agonists. Pharm Biochem Behav. 2003;74:541\u20139.","journal-title":"Pharm Biochem Behav"},{"key":"2225_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/dev.21808","volume":"61","author":"J Mohammadian","year":"2019","unstructured":"Mohammadian J, Najafi M, Miladi-Gorji H. Effect of enriched environment during adolescence on spatial learning and memory, and voluntary consumption of morphine in maternally separated rats in adulthood. Dev Psychobiol. 2019;61:615\u201325.","journal-title":"Dev Psychobiol"},{"key":"2225_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.toxlet.2006.05.007","volume":"166","author":"JJ Strandberg","year":"2006","unstructured":"Strandberg JJ, Kugelberg FC, Alkass K, Gustavsson A, Zahlsen K, Spigset O, et al. Toxicological analysis in rats subjected to heroin and morphine overdose. Toxicol Lett. 2006;166:11\u201318.","journal-title":"Toxicol Lett"},{"key":"2225_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jps.3030480502","volume":"48","author":"JR Nichols","year":"1959","unstructured":"Nichols JR, Davis WM. Drug addiction. II. Variation of addiction. J Am Pharm Assoc Am Pharm Assoc. 1959;48:259\u201362.","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"key":"2225_CR43","doi-asserted-by":"publisher","first-page":"e0178011","DOI":"10.1371\/journal.pone.0178011","volume":"12","author":"C Oses","year":"2017","unstructured":"Oses C, Olivares B, Ezquer M, Acosta C, Bosch P, Donoso M, et al. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy. PLoS One. 2017;12:e0178011.","journal-title":"PLoS One"},{"key":"2225_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"2225_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jcyt.2013.09.004","volume":"16","author":"JA Zimmermann","year":"2014","unstructured":"Zimmermann JA, McDevitt TC. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. Cytotherapy. 2014;16:331\u201345.","journal-title":"Cytotherapy"},{"key":"2225_CR46","unstructured":"Waynforth H, Flecknell P. Experimental and Surgical Technique in the Rat. Elsevier Academic Press 1992."},{"key":"2225_CR47","doi-asserted-by":"publisher","first-page":"e12853","DOI":"10.1111\/adb.12853","volume":"26","author":"Y Israel","year":"2021","unstructured":"Israel Y, Quintanilla ME, Ezquer F, Morales P, Santapau D, Berrios-Carcamo P, et al. Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation-oxidative stress self-perpetuation. Addict Biol. 2021;26:e12853.","journal-title":"Addict Biol"},{"key":"2225_CR48","first-page":"45","volume":"49","author":"S He","year":"2010","unstructured":"He S, Atkinson C, Qiao F, Chen X, Tomlinson S. Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents. J Am Assoc Lab Anim Sci. 2010;49:45\u201351.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"2225_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-016-0299-y","volume":"7","author":"M Ezquer","year":"2016","unstructured":"Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res Ther. 2016;7:42.","journal-title":"Stem Cell Res Ther"},{"key":"2225_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cnr.2006.09.004","volume":"6","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res. 2006;6:237\u201345.","journal-title":"Clin Neurosci Res"},{"key":"2225_CR51","doi-asserted-by":"publisher","first-page":"7313090","DOI":"10.1155\/2017\/7313090","volume":"2017","author":"M Herbet","year":"2017","unstructured":"Herbet M, Korga A, Gawronska-Grzywacz M, Izdebska M, Piatkowska-Chmiel I, Poleszak E, et al. Chronic Variable Stress Is Responsible for Lipid and DNA Oxidative Disorders and Activation of Oxidative Stress Response Genes in the Brain of Rats. Oxid Med Cell Longev. 2017;2017:7313090.","journal-title":"Oxid Med Cell Longev"},{"key":"2225_CR52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1089\/dna.2005.24.736","volume":"24","author":"YX Pan","year":"2005","unstructured":"Pan YX. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 2005;24:736\u201350.","journal-title":"DNA Cell Biol"},{"key":"2225_CR53","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/383819a0","volume":"383","author":"HW Matthes","year":"1996","unstructured":"Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996;383:819\u201323.","journal-title":"Nature"},{"key":"2225_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1196\/annals.1307.047","volume":"1025","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Satoh M. Involvement of glial glutamate transporters in morphine dependence. Ann N. Y Acad Sci. 2004;1025:383\u20138.","journal-title":"Ann N. Y Acad Sci"},{"key":"2225_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.54","volume":"2","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Verweij KJ, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, et al. The genetics of addiction-a translational perspective. Transl Psychiatry. 2012;2:e140.","journal-title":"Transl Psychiatry"},{"key":"2225_CR56","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbi.2008.09.012","volume":"23","author":"MR Hutchinson","year":"2009","unstructured":"Hutchinson MR, Lewis SS, Coats BD, Skyba DA, Crysdale NY, Berkelhammer DL, et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun. 2009;23:240\u201350.","journal-title":"Brain Behav Immun"},{"key":"2225_CR57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.biopsych.2007.06.008","volume":"63","author":"W Zhou","year":"2008","unstructured":"Zhou W, Kalivas PW. N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol Psychiatry. 2008;63:338\u201340.","journal-title":"Biol Psychiatry"},{"key":"2225_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharep.2014.09.006","volume":"67","author":"M Motaghinejad","year":"2015","unstructured":"Motaghinejad M, Karimian M, Motaghinejad O, Shabab B, Yazdani I, Fatima S. Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus. Pharm Rep. 2015;67:230\u20135.","journal-title":"Pharm Rep."},{"key":"2225_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1100\/tsw.2007.230","volume":"7","author":"MR Hutchinson","year":"2007","unstructured":"Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J. 2007;7:98\u2013111.","journal-title":"Sci World J"},{"key":"2225_CR60","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2174\/1871527314666150529144655","volume":"14","author":"DJ Roberts-Wolfe","year":"2015","unstructured":"Roberts-Wolfe DJ, Kalivas PW. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets. 2015;14:745\u201356.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2225_CR61","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1523\/JNEUROSCI.5129-07.2008","volume":"28","author":"RT LaLumiere","year":"2008","unstructured":"LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28:3170\u20137.","journal-title":"J Neurosci"},{"key":"2225_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2013.02.034","volume":"247","author":"AO Abdel-Zaher","year":"2013","unstructured":"Abdel-Zaher AO, Mostafa MG, Farghaly HS, Hamdy MM, Abdel-Hady RH. Role of oxidative stress and inducible nitric oxide synthase in morphine-induced tolerance and dependence in mice. Effect of alpha-lipoic acid. Behav Brain Res. 2013;247:17\u201326.","journal-title":"Behav Brain Res"},{"key":"2225_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2013.01.036","volume":"702","author":"AO Abdel-Zaher","year":"2013","unstructured":"Abdel-Zaher AO, Mostafa MG, Farghly HM, Hamdy MM, Omran GA, Al-Shaibani NK. Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice. Eur J Pharm. 2013;702:62\u201370.","journal-title":"Eur J Pharm"},{"key":"2225_CR64","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/0271678X18776802","volume":"38","author":"CJ Cunningham","year":"2018","unstructured":"Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38:1276\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2225_CR65","doi-asserted-by":"crossref","unstructured":"Farfan N, Carril J, Redel M, Zamorano M, Araya M, Monzon E, et al. Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia. Int J Mol Sci. 2020; 21.","DOI":"10.3390\/ijms21207800"},{"key":"2225_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/biof.1563","volume":"45","author":"SA Muhammad","year":"2019","unstructured":"Muhammad SA. Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury. Biofactors. 2019;45:880\u201391.","journal-title":"Biofactors"},{"key":"2225_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep32096","volume":"6","author":"Z Hua","year":"2016","unstructured":"Hua Z, Liu L, Shen J, Cheng K, Liu A, Yang J, et al. Mesenchymal stem cells reversed morphine tolerance and opioid-induced hyperalgesia. Sci Rep. 2016;6:32096.","journal-title":"Sci Rep."},{"key":"2225_CR68","doi-asserted-by":"publisher","first-page":"645","DOI":"10.14348\/molcells.2016.0137","volume":"39","author":"J Kim","year":"2016","unstructured":"Kim J, Ham S, Hong H, Moon C, Im HI. Brain reward circuits in morphine addiction. Mol Cells. 2016;39:645\u201353.","journal-title":"Mol Cells"},{"key":"2225_CR69","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ijnp\/pyx050","volume":"20","author":"S Spencer","year":"2017","unstructured":"Spencer S, Kalivas PW. Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol. 2017;20:797\u2013812.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2225_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0306-4603(91)90038-J","volume":"16","author":"N Heather","year":"1991","unstructured":"Heather N, Stallard A, Tebbutt J. Importance of substance cues in relapse among heroin users: comparison of two methods of investigation. Addict Behav. 1991;16:41\u201349.","journal-title":"Addict Behav"},{"key":"2225_CR71","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159:592\u2013600.","journal-title":"Ann Intern Med"},{"key":"2225_CR72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.36076\/ppj.2011\/14\/249","volume":"14","author":"N Sehgal","year":"2011","unstructured":"Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician. 2011;14:249\u201358.","journal-title":"Pain Physician"},{"key":"2225_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","volume":"1","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pr Perspect. 2002;1:13\u201320.","journal-title":"Sci Pr Perspect"},{"key":"2225_CR74","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/MLR.0000000000000731","volume":"55","author":"IP Bhalla","year":"2017","unstructured":"Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder. Med Care. 2017;55:S24\u2013S32.","journal-title":"Med Care"},{"key":"2225_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pnpbp.2015.11.004","volume":"65","author":"CE Van Skike","year":"2016","unstructured":"Van Skike CE, Maggio SE, Reynolds AR, Casey EM, Bardo MT, Dwoskin LP, et al. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:269\u201387.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2225_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0306-4603(98)00128-2","volume":"25","author":"S Magura","year":"2000","unstructured":"Magura S, Rosenblum A. Modulating effect of alcohol use on cocaine use. Addict Behav. 2000;25:117\u201322.","journal-title":"Addict Behav"},{"key":"2225_CR77","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1081\/JA-120039392","volume":"39","author":"E Puigdollers","year":"2004","unstructured":"Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse. 2004;39:1353\u201368.","journal-title":"Subst Use Misuse"},{"key":"2225_CR78","doi-asserted-by":"crossref","unstructured":"Boys A, Marsden J, Fountain J, Griffiths P, Stillwell G, Strang J. What influences young people\u2019s use of drugs? a qualitative study of decision-making. Drugs: Educ Prevent Policy. 1999;6.","DOI":"10.1080\/09687639997052"},{"key":"2225_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22750-7","volume":"8","author":"F Ezquer","year":"2018","unstructured":"Ezquer F, Morales P, Quintanilla ME, Santapau D, Lespay-Rebolledo C, Ezquer M, et al. Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking. Sci Rep. 2018;8:4325.","journal-title":"Sci Rep."},{"key":"2225_CR80","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/adb.12675","volume":"24","author":"F Ezquer","year":"2019","unstructured":"Ezquer F, Quintanilla ME, Morales P, Santapau D, Ezquer M, Kogan MJ, et al. Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking. Addict Biol. 2019;24:994\u20131007.","journal-title":"Addict Biol"},{"key":"2225_CR81","unstructured":"Trust P https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/data-visualizations\/2021\/the-high-price-of-the-opioid-crisis-2021. 2021."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02225-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T10:03:27Z","timestamp":1667729007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02225-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"type":"electronic","value":"2158-3188"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}